5 Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; Pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia